Previous Close | 0.3602 |
Open | 0.3600 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 0.3446 - 0.3863 |
52 Week Range | 0.3050 - 2.6550 |
Volume | |
Avg. Volume | 148,996 |
Market Cap | 26.716M |
Beta (5Y Monthly) | 0.64 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.7900 |
Earnings Date | Nov 06, 2024 - Nov 11, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 2.00 |
CERRITOS, Calif., Aug. 13, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its three and six months ended June 30, 2024 and updated its full year 2024 guidance. Recent Operational Highlights Include 76% increase in Dispensary segment revenue compared to prior year quarter3 new capitation contracts signed across 2 states including both m
CERRITOS, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its second quarter 2024 financial results after the market close on Tuesday, August 13, 2024, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time). The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers,
Insiders were net buyers of The Oncology Institute, Inc.'s ( NASDAQ:TOI ) stock during the past year. That is, insiders...